Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GMPs not enough – CSPI

This article was originally published in The Tan Sheet

Executive Summary

The Center for Science in the Public Interest says dietary supplement good manufacturing practices are not enough to ensure supplements are safe and effective because quality control measures are left up to companies. The consumer advocacy group also asserts the regulation will not "address whether the products carry adequate directions for use and appropriate warnings." FDA posted the long-awaited GMPs for advanced display on the Federal Register June 22 (1"The Tan Sheet" June 25, 2007, p. 3). While firms must retain all records of adverse events FDA will only investigate high-risk firms and "given FDA's limited resources that may be as infrequently as once every 5 or 10 years," CSPI says...
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS100661

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel